Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Alzheimer's
Biotech
Eisai rebuts report that Alzheimer's med contributed to death
A New England Journal of Medicine entry highlights a potential risk for patients taking Eisai's Alzheimer's med lecanemab.
Annalee Armstrong
Jan 4, 2023 5:33pm
Japan greenlights Sysmex's amyloid blood test for Alzheimer's
Dec 22, 2022 10:30am
Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step
Nov 30, 2022 10:40am
Lilly powers through final stretch in critical Alzheimer's race
Nov 1, 2022 12:10pm
Lecanemab may have contributed to patient death: report
Oct 28, 2022 10:42am
Biogen's lecanemab commercialization role 'not yet determined'
Oct 25, 2022 11:10am